ライフサイエンスコーパス: heart and lung transplantation

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 rizes the recent changes and advancements in heart and lung transplantation.

2 changes in practice and future directions of heart and lung transplantation.

3 hypertension, who were referred for lung or heart and lung transplantation.

4 opathology (ISHLT [International Society for Heart and Lung Transplantation] 2013 grades), immunostai

5 an Sharing and the International Society for Heart and Lung Transplantation, all adult primary heart

6 ogy, Neurosurgery and Psychiatry, Journal of Heart and Lung Transplantation, American Journal of Tran

7 e of DSA HLA antibodies should be avoided in heart and lung transplantation and considered a risk fac

8 th the help of the International Society for Heart and Lung Transplantation and The Transplantation S

9 ontributed much to the success rates of both heart and lung transplantation, and by 2001, it had beco

10 ociety of America, International Society for Heart and Lung Transplantation, and Interagency Registry

11 ociety of America, International Society for Heart and Lung Transplantation, and the Interagency Regi

12 ared with the 1990 International Society for Heart and Lung Transplantation AR grades.

13 cal Care Medicine, International Society for Heart and Lung Transplantation, Association of Organ Pro

14 se according to the International Society of Heart and Lung Transplantation criteria.

15 defined using the International Society for Heart and Lung Transplantation criteria.

16 as measured per the International Society of Heart and Lung Transplantation: "current FEV1/ baseline

17 n according to the International Society for Heart and Lung Transplantation definition.

18 rejection in 15% (International Society for Heart and Lung Transplantation grade > 3A).

19 cute rejection with International Society of Heart and Lung Transplantation grade > or =3A (24% vs. 3

20 or rejection, fewer International Society of Heart and Lung Transplantation grade > or =3A rejections

21 ence of rejection (International Society for Heart and Lung Transplantation grade > or =3A) when comp

22 logical AMR (pAMR) International Society for Heart and Lung Transplantation grade (P<0.001) and assoc

23 with no rejection (International Society of Heart and Lung Transplantation grade 0).

24 ), and 89%(8/9) of International Society For Heart and Lung Transplantation grade 0, 1, 2, and 3 biop

25 AR was defined as International Society for Heart and Lung Transplantation grade 2R or higher cellul

26 ping rejection (>/= International Society of Heart and Lung Transplantation grade 2R); however, the f

27 rimary outcome was International Society for Heart and Lung Transplantation grade 3 PGD at 48 or 72 h

28 rimary outcome was International Society for Heart and Lung Transplantation grade 3 PGD within 72 hou

29 ection, defined as International Society for Heart and Lung Transplantation grade 3A or higher (P<0.0

30 llograft rejection (International Society of Heart and Lung Transplantation grade 3A/B) were compared

31 ejection (at least International Society for Heart and Lung Transplantation grade 3A; n=7); and (3) s

32 with rejection and International Society for Heart and Lung Transplantation grade and the performance

33 ates, or rejection (International Society of Heart and Lung Transplantation grades 0-4).

34 reliability of the International Society for Heart and Lung Transplantation grading system; problem a

35 psies according to International Society for Heart and Lung Transplantation guidelines.

36 A new rat model of heterotopic heart and lung transplantation has been developed for MR

37 ory Support of the International Society for Heart and Lung Transplantation has established an intern

38 Heart and lung transplantation has gained acceptance as

39 A committee of the International Society for Heart and Lung Transplantation has reviewed the current

40 nd offers great hope for children undergoing heart and lung transplantation in the future.

41 nd recent evidence for mTOR inhibitor use in heart and lung transplantation is examined in this revie

42 e.The impact of HCV infection on survival in heart and lung transplantation is unclear.

43 ion was defined as International Society for Heart and Lung Transplantation (ISHLT) grade 2R or highe

44 The International Society of Heart and Lung Transplantation (ISHLT) has initiated a m

45 zed criteria of the International Society of Heart and Lung Transplantation (ISHLT).

46 tered in the Joint International Society for Heart and Lung Transplantation (ISHLT)/United Network fo

47 h-grade rejections (International Society of Heart and Lung Transplantation [ISHLT] grade > or = 3A/4

48 The recent International Society for Heart and Lung Transplantation listing criteria for hear

49 ed according to the International Society of Heart and Lung Transplantation nomenclature.

50 Much progress has been made in heart and lung transplantation over recent decades.

51 the subject by the International Society for Heart and Lung Transplantation Pulmonary Council.

52 k for Organ Sharing/International Society of Heart and Lung Transplantation registry between 1994 and

53 herapy (rejectors; International Society for Heart and Lung Transplantation rejection grade >/= 2R) a

54 found between the International Society for Heart and Lung Transplantation rejection grade and expre

55 d based on the 2004 International Society of Heart and Lung Transplantation rejection grading system.

56 yte damage, and the International Society of Heart and Lung Transplantation score fell from 5 to 4 an

57 ed according to the International Society of Heart and Lung Transplantation system, with a range of 0

58 tly reported to the International Society of Heart and Lung Transplantation that, by combining the us

59 death based on the International Society for Heart and Lung Transplantation working formulation.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。